443 filings
Page 2 of 23
6-K
pkrioskj
6 Nov 23
Current report (foreign)
4:30pm
6-K
h0mhpma r8a92
2 Nov 23
Current report (foreign)
4:35pm
6-K
crrtqlr
1 Nov 23
Current report (foreign)
4:35pm
6-K
owmwvalvtp9
1 Nov 23
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
6:44am
20-F/A
3tvvddy
31 Oct 23
Annual report (foreign) (amended)
5:10pm
6-K
eyz5q vo4r
31 Oct 23
Current report (foreign)
5:09pm
6-K
kry8d3
31 Oct 23
Current report (foreign)
4:35pm
6-K
epva39w 2b
24 Oct 23
Cellectis to Present Pre-Clinical Data on HSPC Gene Therapy Program and Comprehensive Analysis of TALE-BE at the ESGCT 30th Annual Congress
4:35pm
6-K
rv2nb1t8 ge
12 Oct 23
Current report (foreign)
4:35pm
6-K
vwjyq4te
27 Sep 23
Current report (foreign)
4:35pm
6-K/A
1z9lyvtk s9
5 Sep 23
Current report (foreign) (amended)
4:32pm
S-8
g5xb6mtpmx0zex
7 Aug 23
Registration of securities for employees
5:05pm
6-K
mhx82
7 Aug 23
Cellectis Provides Full Report for Second Quarter 2023 Financial Results
4:35pm
6-K
q6aqa
7 Aug 23
Current report (foreign)
4:17pm
6-K
f59qx quzlp7ti
3 Aug 23
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
4:35pm
6-K
0u9405s10
27 Jul 23
Current report (foreign)
4:35pm
6-K
p06m ng89e
12 Jul 23
Cellectis Appoints Dr. Cécile Chartier, Ph.D. to its Board of Directors
12:00am
6-K
8gzfehe d46zo1
29 Jun 23
Current report (foreign)
8:23am
6-K
erql2 0jk
28 Jun 23
Current report (foreign)
4:57pm
6-K
4bl8v93bgzk6y
9 Jun 23
Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023
4:35pm